drugset / Trial / NCT03076099

Dexmedetomidine on Post-operative Blood Pressure in Bain Arteriovenous Malformation Embolization

NCT03076099 ↗

Unknown 30 enrolled Nan Jiang
RandomizedParallel-groupTriple-blindTreatment

Summary

Aim of this trial is to study the effect of Dexmedetomidine on post-operative blood pressure in patients undergoing brain arteriovenous malformation embolization. The patients were randomized allocated to either Dexmedetomidine group or Control group. Patients in Dexmedetomidine group will receive intravenous Dexmedetomidine while the control group will receive normal saline. Post-operative anti-hypertensive drug, Visual analogue score,post-operative analgesics consumption, Quality of Recovery score, Ramsay score, and adverse events were recorded.

Timeline

Start
2016-01-01
Primary completion
2017-12-31
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 1.2 ug/kg Intravenous

Indications

No indication recorded.